删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

上海交通大学医学院研究生导师简介 郎靖瑜

上海交通大学 免费考研网/2013-01-10

基本信息
导师姓名: 郎靖瑜 专业代码: 071009
性别: 专业名称: 细胞生物学
培养单位: 健康科学研究所 三级学科/
专业领域:
未设
导师类型: 博士生导师 专业学位导师:
联系方式: jylang@sibs.ac.cn 上海市重庆南路225号5号楼202室 200025Tel:021-63852704
研究方向 (点击浏览详细信息)
肿瘤干细胞与靶向治疗
社会任职
2004 美国癌症研究协会会员
科研项目
项目编号项目名称课题来源起止时间科研经费承担职责
2乳腺癌干细胞分子靶点发现及其靶向药物研究中科院方向性项目2012-09~~2015-0950万元主要责任人
1乳腺癌干细胞的分子机制研究中组部青年****2012-02~~2015-02200万元主要责任人
学术论文 (#为通讯作者,*为共同第一作者)

1、Lang JY, Shi Y, Chin YE.. Reprogramming Cancer Cells: Back to the Future. Oncogene,2012;in press
2、Wang Y, Ding Q, Yen CJ, Xia WY, Izzo J, Lang JY, Li CW, Miller S, Wang X, Lee DF, Hsu JL, HsuJM, Huo L, LaBaff A, Liu DP, Huang TH, Lai CC, Tsai FJ, Chang WC, Chen CH, Wu TT, Buttar N,Wang K, Wu Y, Wang H, Ajani, J, Hung MC.. The Crosstalk of mTOR/S6K1 and Hedgehog Pathways. Cancer Cell,2012;21(3):374-387
3、Wei Y, Chen YH, Li LY, Lang J, Yeh SP, Shi B, Yang CC, Yang JY, Lin CY, Lai CC, Hung MC.. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenicdifferentiation of human mesenchymal stem cells. Nat Cell Biol,2011;13(1):87-94
4、Lang JY, Hsu JL, Meric-Bernstam F, Chang CJ, Wang QF, Bao Y, Yamaguchi H, Xie X, WoodwardWA, Yu D, Hortobagyi GN, Hung MC.. BikDD eliminates breast cancer initiating cells and synergizeswith lapatinib for breast cancer treatment. Cancer Cell,2011;20(3):341-356
5、Banerjee A, Lang JY, Hung MC, Sengupta K, Banerjee SK, Baksi K, Banerjee DK.. Unfolded proteinresponse is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin. J Biol Chem,2011;286(33):29127-29138
6、Ding Q, Chang CJ, Xie X, Xia W, Yang JY, Wang SC, Wang Y, Xia J, Chen L, Cai C, Li H, Yen CJ,Kuo HP, Lee DF, Lang J, Huo L, Cheng X, Chen YJ, Li CW, Jeng LB, Hsu JL, Li LY, Tan A, CurleySA, Ellis L, DuBois RA, Hung MC.. APOBEC3G promotes liver metastasis in an orthotopic mouse modelof colorectal cancer and predicts human hepatic metastasis. J Clin Invest,2011;121 (11):4526-36
7、Jiang T, Grabiner B, Zhu Y, Jiang C, Li H, You Y, Lang J, Hung MC, Lin X.. CARMA3 is crucial forEGFR-induced activation of NF-kB and tumor progression. Cancer Res,2011;71(6):2183-92
8、Song H, Li CW, Labaff AM, Lim SO, Li LY, Kan SF, Chen Y, Zhang K, Lang J, Xie X, Wang Y, HuoLF, Hsu SC, Chen X, Zhao Y, Hung MC.. Acetylation of EGF receptor contributes to tumor cell resistanceto histone deacetylase inhibitors. Biochem Bioph Res Co,2011;404(1):68-73
9、Li LY, Dai HY, Yeh FL, Kan SF, Lang J, Hsu JL, Jeng LB, Chen YH, Sher YP, Lin WC, Hung MC.. Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy. Oncogene,2010;30(15):1773-83
10、Cheng X, Xia W, Yang JY, Hsu JL, Lang JY, Chou CK, Du Y, Sun HL, Wyszomierski SL, Mills GB,Muller WJ, Yu D, Hung MC.. Activation of murine double minute 2 by Akt in mammary epitheliumdelays mammary involution and accelerates mammary tumorigenesis. Cancer Res,2010;70(19):7684-9
11、Usami Y, Nakagawa-Goto K, Lang JY, Kim Y Lai CY, Goto M, Sakurai N, Taniguchi M, Akiyama T,Morris-Natschke SL, Bastow KF, Cragg G, Newman DJ, Fujitake M, Takeya K, Hung MC, Lee EY, LeeKH. Antitumor Agents. 282. 2 '-(R)-O-Acetylglaucarubinone, a Quassinoid from Odyendyea gabonensis3As a Potential Anti-Breast and Anti-Ovarian Cancer Agent. J Nat Prod,2010;73(9):1553-8
12、Dong Y, Shi Q, Pai HC, Peng CY, Pan SL, Teng CM, Nakagawa-Goto K, Yu D, Liu YN, Wu PC,Bastow KF, Morris-Natschke SL, Brossi A, Lang JY, Hsu JL, Hung MC, Lee EY, Lee KH.. Antitumoragents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neotanshinlactoneanalogues. J Med Chem,2010;53(5):2299-2308
13、Dong Y, Shi Q, Nakagawa-Goto K, Wu PC, Morris-Natschke SL, Brossi A, Bastow KF, Lang JY, HungMC, Lee KH.. Novel substituted 6-phenyl-4H-furo [3,2-c]pyran-4-one derivativesas potent and highly selective anti-breast cancer agents. Bioorgan Med Chem,2010;18(2):803-8
14、Zhou J, Chen Y, Lang JY, Lu JJ, Ding J.. Salvicine inactivates beta 1 integrin and inhibits adhesion ofMDA-MB-435 cells to fibronectin via reactive oxygen species signaling. Mol Cancer Res,2008;6(2):194-204
15、Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC,Huang H, Kuo HP, Lee DF, Li LY, Lien HC, Cheng X, Chang KJ, Hsiao CD, Tsai FJ, Tsai CH, SahinAA, Muller WJ, Mills GB, Yu D, Hortobagyi GN, Hung MC.. ERK promotes tumorigenesis by inhibitingFOXO3a via MDM2-mediated degradation. Nat Cell Biol,2008;10(2):138-48
16、Hung MC, Xie XM, Lang JY.. Cancer-Specific Promoters. 美国专利,2008;PCT/US2007/085223
17、Xie X, Xia W, Li Z, Kuo HP, Liu Y, Li Z, Ding Q, Zhang S, Spohn B, Yang Y, Wei Y, Lang JY, EvansDB, Chiao PJ, Abbruzzese JL, Hung MC.. Targeted expression of BikDD eradicates pancreatic tumors innoninvasive imaging models. Cancer Cell,2007;12(1):52-65
18、Lang JY, Chen H, Zhou J, Zhang YX, Zhang XW, Li MH, Lin LP, Zhang JS, Waalkes MP, Ding J.. Antimetastasiseffect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closelyrelated to Rho-dependent pathway. Clin Cancer Res,2005;11(9):3455-64
19、Tong Y, Zhang X, Zhao W, Zhang Y, Lang J, Shi Y, Tan W, Li M, Zhang Y, Tong L, Lu H, Lin L, DingJ.. Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used totreat rheumatoid arthritis. Eur J Pharmacol,2004;494 (2-3): 101-109


版权所有 ? 2009 上海交通大学研究生院医学院分院上海市重庆南路227号 邮编:200025
电子邮件:yjsy@shsmu.edu.cn 总机:63846590
相关话题/导师 医学